Resistance to Antimalarial Drugs: Molecular, Pharmacologic, and Clinical Considerations

Abstract

One of the greatest obstacles to the control of malaria has been the spread of resistance to drugs used on a large scale. This review provides an update of the current understanding of the molecular basis for antimalarial drug resistance. Parasite intrinsic resistance is just one component that determines the in vivo efficacy of a drug. Human immune responses and pharmacologic properties play important roles in determining the clinical outcome of treatment. The emergence and spread of resistance also results from an interplay of these factors. Current efforts to characterize and deter resistance to new combination therapy are also discussed.

DOI: 10.1203/PDR.0b013e3181a0977e
050100200920102011201220132014201520162017
Citations per Year

221 Citations

Semantic Scholar estimates that this publication has 221 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Travassos2009ResistanceTA, title={Resistance to Antimalarial Drugs: Molecular, Pharmacologic, and Clinical Considerations}, author={Mark A. Travassos and Miriam K Laufer}, journal={Pediatric Research}, year={2009}, volume={65}, pages={64R-70R} }